Unedited news and product information from vendors.
PCMA Statement: FTC to New York: Anti-Mail-Service Pharmacy Bill Would Hurt Consumers, Raise Drug Costs
Aug 08, 2011 (04:08 PM EDT)
FTC Recommends Bill 'Not be Enacted'
WASHINGTON, Aug. 8, 2011 /PRNewswire-USNewswire/ -- In a letter to New York State Senator James Seward, the Federal Trade Commission (FTC) warned that Assembly Bill 5502-B, which would restrict employers' ability to save money by offering lower cost home delivery options for chronic medications, would have the "unintended consequence of harming consumers" and would likely "raise prices for, and reduce access to, prescription drugs, which are an increasingly important component of medical care." For these reasons, the FTC recommended the bill "not be enacted."
"The Federal Trade Commission's comments on the anti-mail-service pharmacy bill make it clear that it would harm consumers by limiting access and raising their prescription drug costs," said Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt. "Governor Cuomo should veto this prescription drug tax on small business. It pads drugstore profits and sticks employers with the tab."
Home delivery is popular with patients because it offers lower cost 90-day prescriptions for long-term, chronic conditions and is more convenient than driving to the drugstore every 30 days. With mail-service pharmacies, patients can get private counseling over the phone from trained pharmacists seven days a week, 24 hours a day. Numerous government and peer-reviewed studies have confirmed the increased savings, safety, and adherence provided by mail-service pharmacies, including:
PCMA represents the nation's pharmacy benefit managers (PBMs), which improve
affordability and quality of care through the use of electronic prescribing (e-prescribing),
generic alternatives, mail-service pharmacies, and other innovative tools for 200-plus million Americans.
SOURCE Pharmaceutical Care Management Association